目次

Chapter- 1: Introduction
Overview
Study Goals and Objectives
Reasons for Doing This Study
Scope of the Report
What's New in This Update?
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table 0A : Global Market for Cardiac Biomarkers, by Type of Biomarker, Through 2027
Figure 0A : Global Market Shares of Cardiac Biomarkers, by Type of Biomarker, 2021
Table 0B : Global Market Shares of Cardiac Biomarkers, by Region, 2021
Figure 0B : Global Market Shares of Cardiac Biomarkers, by Region, 2021

Chapter- 3: Cardiovascular Disease and Its Associated Burden
Overview of Cardiovascular Disease
Atherosclerosis
Angina (Angina Pectoris)
Acute Myocardial Infarction (AMI)
Disease Management
Medical Management
Lifestyle Changes
Diet Modification
Smoking Cessation
Pharmaceuticals
Anticoagulants and Antiplatelet Drugs
Lipid-Lowering Drugs
Anti-hypertensive Drugs
Nitroglycerin Preparations
Surgical Intervention
Global Burden of Cardiovascular Disease

Chapter- 4: Introduction to Cardiac Biomarkers
Types of Biomarkers
Role of Biomarkers in the Prevention, Assessment and Management of Heart Failure
Biomarker Discovery and Validation
Omic Technologies for Biomarker Discovery
Considerations When Developing a Cardiac Biomarker
Defining Abnormal Biomarker Values
Receiver Operating Characteristic Curve Analysis of Biomarker Accuracy

Chapter- 5: Review of Key Individual Cardiac Biomarkers
Gold Standard of Cardiac Biomarkers
Troponin Complex
Pro-BNP and/or NT-proBNP
Creatine Kinase Test
Myoglobin (Mb)
C-Reactive Protein
Other Key Cardiac Biomarkers
Emerging Cardiac Biomarkers
Recent Technological Advances and Key Developments in Cardiac Biomarker Measurement

Chapter- 6: Global Market for Cardiac Biomarkers
Introduction
Global Market for Cardiac Biomarkers, by Type of Biomarker
North American Market
European Market
Asia-Pacific Market
Rest of World Market

Chapter- 7: Impact of the COVID-19 Pandemic
Overview
Impact of COVID-19 on the Market for Cardiac Biomarkers

Chapter- 8: Regulatory and Legislative Requirements for Cardiac Biomarkers
North America
Europe
Japan
China
India
South Korea
Brazil
Argentina
Mexico

Chapter- 9: Patent Review and New Developments in Cardiac Biomarkers
Introduction
Cardiac Biomarker Patents, by Region and Country

Chapter- 10: Competitive Landscape
Company Market Share Analysis
Recent News

Chapter- 11: Company Profiles
ABBOTT LABORATORIES
ACS BIOMARKER BV
BECKMAN COULTER (SUBSIDIARY OF DANAHER CORP.)
BG MEDICINE INC.
BIOMERIEUX S.A.
BIO-RAD LABORATORIES, INC.
CARDIOGENICS
CREATIVE DIAGNOSTICS
CRITICAL DIAGNOSTICS
LIFE DIAGNOSTICS INC.
LIFESIGN
LSI MEDIENCE CORP.
MERIDIAN LIFE SCIENCE INC.
METANOMICS HEALTH GMBH
ORTHO-CLINICAL DIAGNOSTICS INC.
PERKINELMER INC.
PTS DIAGNOSTICS
QUIDEL CORP.
RADIOMETER MEDICAL APS
RANDOX LABORATORIES LTD.
RESPONSE BIOMEDICAL CORP.
ROCHE DIAGNOSTICS
SANYO CHEMICAL INDUSTRIES LTD.
SIEMENS AG
SINGULEX INC.
SPECTRAL MEDICAL INC.
THERMO FISHER SCIENTIFIC, INC.
TOSOH BIOSCIENCE INC.
TRINITY BIOTECH PLC

Chapter- 12: Appendix A: Company Addresses and Contact Details
Company Addresses and Contact Details

Chapter- 13: Appendix B: Government Regulatory Agencies and Professional Organizations
Government Regulatory Agencies and Professional Organizations

Chapter- 14: Appendix C: Commonly Used Acronyms Associated with Cardiac Biomarkers
Table 100 : Commonly Used Acronyms Associated with Cardiac Biomarkers